1 ticoid receptor sensitivity, measured by the dexamethasone suppression test.

2 asured after an overnight low-dose (0.25 mg) dexamethasone suppression test and a potentially stressf

3                 The panel recommended a 1-mg dexamethasone suppression test and measurement of plasma

4 ma cortisol decline on the low-dose (.50 mg) dexamethasone suppression test, and 24-hour urinary cort

5                                              Dexamethasone suppression test (DST) data were available

6            Previous studies using the 1.0-mg dexamethasone suppression test (DST) in subjects with pe

7               Fourteen studies that compared dexamethasone suppression test (DST) results in psychoti

8 and historical risk factors with that of the dexamethasone suppression test (DST), a clinically pract

9 unction with a weight-adjusted very-low-dose dexamethasone suppression test (DST), and a psychologica

10 evaluation, urinary free cortisol levels and dexamethasone suppression tests (DSTs) were obtained.

11                  The authors used a low-dose dexamethasone suppression test to examine the effect of

12 ormonal activity, including a 1-mg overnight dexamethasone suppression test, total 24-hour urinary me

13                                            A dexamethasone suppression test was performed to assess n

14 cortisol excretion and an overnight low-dose dexamethasone suppression test were done to screen for C